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A PLUTONIUM-INDUCED osteosarcoma
propagated in CBA/Ca mice was trans-
planted s.c. into a congenic strain bearing
an isoenzyme (GPI) and chromosome (T6)
difference from the last strain. After 4
successive passages in the new host, the
tumour, when excised and homogenized,
was found to possess a mixture oftwo GPI
phenotypes, one derived from the original
tumour cells and the other from the new
host. During subsequent tissue culture,
fusion appeared to occur between tumour
and host cells as indicated by the detection
ofthe heterogeneous (a/ dimer) isoenzyme
of GPI. The proportion of heterogeneous
GPI increased rapidly in cultured cells
which formed tumours showing the same
GPI pattern when inoculated s.c. into mice
ofthe original host strain. Although inter-
and intraspecific hybrid cells can be
induced in culture by viral action, we
describe an example of apparently spon-
taneous fusion between tumour and
adventitious host cells. Monitoring of GPI
isoenzymes can provide a quantitative
assessment of fusion between the cells
from strains of mice which are hetero-
geneic for Gpi-1.
The tumour was originally induced in
CBA/H mice and maintained by s.c.
transplantation in CBA/Ca mice for 8
years. The congenic CBA/H-T6.A-Gpi_1a
line was produced by 11 generations of
backcrossing strain A into CBA/H-T6 mice
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with selection of GPI-1AB, followed by
brother-sister incrossing to obtain homo-
geneous Gpi-la progeny. The CBA/H-T6
strain is congenic with our CBA/Ca strain.
Transplant tolerance between all these
lines was confirmed by skin grafting.
A cell suspension from the solid tumour
was obtained using trypsin (025% in
Earl's BSS without Ca2+ or Mg2+) and
established in 25 cm2 Sterilin polystyrene
flasks containing Waymouth's MB 752/1
medium+10% FBS (Flow Laboratories).
Subcultures were made at 3, 6 and 28 days
after initiation using EDTA/trypsin
(001%/0.1 %) to detach cells. Detached
cells were cultured separately, while cells
not detached by this treatment were fed
again with fresh medium. All cultures
received a fluid change every 3-4 days.
GPI isoenzymes were assayed by the
method of Marshall & Worsfold (1978).
This method consists of a micro-prepara-
tive electrophoresis apparatus linked to an
auto-analysis system for GPI. Fig. 1 shows
examples of recorder traces of electro-
phoresed GPI patterns from tumour
samples. After the first passage ofGPI-1B
tumour in GPI-1A mice an entire tumour
was homogenized. Electrophoresis of a
sample of this homogenate demonstrated
approximately 60% GPI-1B (/8 dimer)
derived from the original mouse in which
the tumour was induced and 40% GPI-1A
characteristic of the new host (oaoa dimer).
* Supported by the Cancer Research Campaign.
54M. J. MARSHALL, D. G. SHONE, J. M. WINDLE AND M. WORSFOLD
2 25
hours
Fia. 1. Recorder tracesshowing GPIactivity
from cell lysates after elution from the
electrophoresis apparatus. The scale is a
linear absorbance scale and is proportional
to GPI activity. (a) Tumour at the end of
passage in a CBA/-T6.A-Gpi-la mouse
showing GPI-IB and GPI-IA and no
significant GPI-1AB. (b) Adherent tumour
cells at the end of passage 3 in cell culture
showing a GPI-IAB pattern. (c) Detached
tumour cells at the end of pasage 3 in cell
culture showing a GPI-lAB pattern added
to a GPI-lB component. (d) A red cell
haemolysate from Gpi-la x Gpi-lb hybrid
mouse showing a typical GPI-I AB pattern.
This type of pattern is referred to as
dimorphic, being an additive mixture of
the two monomorphic (GPI-1A and GPI-
1B) patterns. This ratio remained fairly
constant through 4 successive passages
into GPI-1A mice (Table). On culturing
cells from this tumour for 2 passages a
similar GPI pattern was observed, suggest-
ing a stable relationship between normal
and malignant cells. However, at the end
ofthe third passage a polymorphic pattern
was detected in cells detached after
treatment with EDTA/trypsin and cul-
tured separately, i.e. some components
were present, notably a large peak in the
position expected of the heterogeneous
(ap) enzyme dimer, which could not be the
result of addition of GPI-IA or GPI-1B
phenotypic patterns in any proportions.
These patterns appeared to be a mixture of
mainly GPI-1B and GPI-1AB phenotypic
patterns. (Note that the GPI-1AB pheno-
type consists ofa mixture of otoz, ap and ,8,8
isoenzymes in the proportion 1:2: 1.) Cells
which remained adherent to the substrate
after EDTA/trypsin treatment yielded
patterns which were either polymorphic,
with a predominance ofGPI-1AB pattern,
or were entirely of GPI-1AB phenotype,
within the quantitative limits ofthe assay
(about 500). The GPI pattern of these
latter cells was indistinguishable in terms
of the proportions of peak areas from the
GPI pattern obtained from a red cell
haemolysate derived from a (Gpi-lb x
Gpi-la) hybrid mouse. These adherent
cells were passaged 3 x further and a GPI-
lAB phenotypic pattern was obtained for
cells at the end of each passage. One
million of these cells were introduced s.c.
into 3 GPI-1B mice and within 2 weeks a
tumour was palpable in each. At 5 weeks
the tumours were excised and the GPI
pattern of this material was found to be
polymorphic, approximately equivalent to
the combination of 29% of GPI-1B
phenotype with 76% GPI-IAB.
Monitoring the GPI of cultured cells
derived from those detached by EDTA/
trypsin showed, during 3 passages, a
gradual change from the polymorphic
GPI-1AB and GPI-1B pattern to a
monomorphic GPI-1AB pattern (Table).
The morphological changes observed
during culture oftumour cells are shown in
Fig. 2. The culture after 3 days growth
showed an indistinct layer of epithelioid
cells covered with macrophage-like cells
(Fig. 2a). This morphology was retained in
the adherent cell population after treat-
ment with EDTA/trypsin. After the
second passage at 6 days, large multi-
nucleate cells appeared (Fig. 2b) especially
in subconfluent areas. After the third
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TABLE-Analysis of GPI phenotypes in tumour cells
Peak areas
(0° of total)
, A_~~~~~'
Original tumour in GPI-lB mouse
Same tumour passaged in GPI-IA mice
Passage 1
Passage 2
Passage 3
Passage 4
Same tumour in tissue cuilture
Passage 1
Passage
Adherent cells
Passage 3
Passage 4
Detached cells
Passage 3
Passage 4
Passage 5
Tumour formed in GPI-1B mouse
from cultured cells (adlherent passage 4)
Pk 1
92-6
Pk 2
7 -4
57-3
73-1
666
75 0
80-4
61 -9
4-6
5 8
5 0
5 -5
Computeda contributions
of phenotypes
Pk 3 GPI-1B GPI-1AB GPI-IA
0 99 1 0
38-1
21-1
28-4
19-5
6-4 13-0
4 9 33-2
28 7 48 3 23
27-3 49 2 23-5
48 5 36-1 15-4
38-6 42-0 19-4
29-3 47-9 22-8
47-8 36 1 161-
61
78
72
81
86
66
0
-2-5
30
15
1
29
1
0
0
38
21
28
19
1 13
1 33
107 -7
108 -7
76
91
106
76
-6
-6
-7
- 5
a Typical standard phenotypic patterns, expressed as percentages of peaks 1, 2 and 3 respectively were as
follows: GPI-1B; 93:7:0; GPI-lAB; 27:45:28; GPI-1A; 0:0:100. Therefore, for an unknown pattern:
peak 1 total=0-93xB+0-27xAB; peak 2 total=0-07xB+0-45xAB; peak 3 total=0-28xAB+A,
where A, B and AB are the amount contributed by GPI-1A, lB and lAB phenotypic patterns. These 3
simultaneous equations are solved for each assay using a PET microcomputer. Details of the program can
be supplied on request to one of us (M. Worsfold). Significaiit (> 4%) excursions below zero for peaks 1 or
3 indicate that the pattern could not have been formed by simple addition ofany combination ofthe 3 normal
phenotypes (see Discussion).
passage at 28 days, discrete colonies of
epithelioid cells with a single, large nucleus
developed (Fig. 2c) and grew rapidly to
confluence at the expense of all other cell
types. These were the cells that possessed a
stable GPI-1AB phenotype that was
retained for at least 3 further passages.
Mitotically active cultures were exposed
to 0-0040o colchicine for 17 h. Dividing
cells, arrested in metaphase, became
detached from the culture vessel and were
collected by centrifugation.
Mice were injected (i.p.) with 03 ml of
0-0400 colchicine and killed after 1 I h. Cell
suspensions were prepared by mincing
pieces of tumour in warm Medium 199
(Flow Laboratories).
Chromosome preparations were pre-
pared and stained with propionic orcein
(Ford, 1966).
The T6 marker chromosome from the
host mouse was detected in some polyploid
metaphases in tumour cells after 3 pass-
ages in culture.
The weight of evidence for cell fusion in
this study rests on the interpretation of
GPI data although the karyotypic and
morphological observations reinforce this
conclusion. In order for the heterogeneous
(oq3) isoenzyme to be produced both Gpi-la
and Gpi-lb genes must be present within
the same cell (DeLorenzo & Ruddle, 1969).
These authors showed that allophenic
(chimaeric) animals do not show hetero-
geneous (oi) isoenzyme except in extracts
of multinucleate cells. The demonstration
of heterogeneous (oj3) GPI isoenzyme has
been used as evidence of cell fusion
recently by Halaban et al. (1980). They
found that mixed populations of cells
carrying the Gpi-la and Gpi-lb genes did
not produce the (a8) isoenzyme nor was
this isoenzyme produced by freezing and
thawing cell lysates at low ionic strength.
Throughout many bone marrow trans-
plant experiments in which we are cur-
rently engaged, where homozygous GPI
isoenzymes have been used to monitor the
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graft, no heterogeneous (ox/) form has been
detected.
The possibility was considered that the
tumour cells in culture afterpassage 3 may
have been producing disproportionate
amounts ofthe sub-band shown in Fig. la
which migrates at aboutthe position ofthe
heteroeneous (op) isoenzyme. Two obser-
vations make this unlikely: first, the ratio
of this sub-band to the preceding major
band to which it is related, is constant in a
wide range oftissues (Marshall et al., 1979)
including this osteosarcoma. Second, when
cells from the same tumour line grown in a
GPI-1B mouse were cultured for 3 pass-
ages under the same conditions as for the
FIG. 2(a)
Fi.(o. 2(b)
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Fie.. 2(c)
FiG. 2.-Morphology of cultured tumour cells from CBA/H-T6.A-Gpi-la host. x 150. (a) Epithelioid
cells covered by macrophage-like cells after 3 days' growth. (b) Multinucleate cells after the second
passage. (c) Cells with large nuclei after the third passage.
tumour cells from the GPI-1A host, no
increase in the ratio of the sub-band to
main band was observed.
There have been several reports of
spontaneous intraspecific hybridization
between malignant and normal cells
(Scaletta & Ephrussi, 1965; Halaban et al.,
1980) and this process can apparently
occur in vivo (Ber et al., 1978). Thus,
Nabholz et al. (1969) and Wiener et al.
(1972) have discussed the possibility that
fusion between malignant and normal cells
in vivo could be a mechanism of tumour
progression and evolution. Cell fusion
could provide a basis for increased genetic
variation within the tumour cell popula-
tions and on this variation selection could
operate. In these reports the demonstra-
tion of fusion has relied on deliberate
selection for fused cells, usually by the
selective medium HAT in which endogen-
ous synthesis of nucleic acid is blocked by
aminopterin (Littlefield, 1964). In the
current work we present evidence that
fusion has occurred between normal and
malignant cells in the absence of any
added fusing agent and without deliberate
selection for fused cells. The presence of a
viral fusion agent in our cultures was
considered unlikely since growth medium
from the fused cell culture failed to induce
fusion of mouse calvarial fibroblasts, as
indicated by the absence of(ou) isoenzyme
in a mixedpopulation ofGPI-1A and GPI-
1B cultured cells (unpublished data).
The ability to fuse appears to have been
a property ofthe cultured tumour cells. It
seems that the culture conditions either
encouraged fusion or selected for the fused
cells. We came to this conclusion because
fusion was not detected in vivo. Detection
of small numbers of fused cells in the
tumour presents technical difficulties
because of the sub-band already men-
tioned. If fusion of cells had occurred in
vivo these may have been suppressed by
the host. There is evidence that malig-
nancy can be suppressed by fusion be-
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tween malignant and normal cells and that
malignancy of the hybrids is not simply
related to immunogenicity (Kim et al.,
1979).
Whether malignancy behaves as a
recessive or dominant characteristic in this
type of fused cell is a vexed question.
Stanbridge (1976) points to the tendency
for "most mouse cell lines to transform
into heteroploid malignant cell lines in
vitro" and he also states that the lack of
suppression ofmalignancy in fused mouse
cell lines may be due to rapid loss of
chromosomes.
The GPI data presented here do not
allow a distinction between cells derived
by nuclear fusion (polyploid) and multi-
nucleate cells with nuclei of different
provenance. We have, however, obtained
patterns which show a preponderance of
heterogeneous (a#) isoenzyme which could
not be derived from simple addition of
GPI-1A, 1B, and LAB phenotypic pat-
terns, in that the proportion of oxcx
isoenzyme was too low, relative to the
amount of ax,8 isoenzyme. This can only
arise if the a and 3 subunits are syn-
thesized in the cell in unequal proportions.
The observations of the rapid prefer-
ential selection offused cells in vitro in the
absence of added selective agents lends
support to the possibility of this being a
mechanism of tumour cell evolution in
vivo. It may be worth bearing in mind the
possibility of fusion occurring in cultured
tumour cell experiments, adding difficulty
to their interpretation.
We are grateful to Dr J. F. Loutit, Radiobiology
Unit, Harwell, for generously supplying the osteo-
sarcoma in CBA/H mice and to Dr N. W. Nisbet for
karyotypic analysis.
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